A comprehensive view of Genetic Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Biogen sponsors podcast on Swiss hospital financial challenges; Company supports Dementia Action Week in Australia, emphasizes patient safety on World Patient Safety Day
Published:
September 18, 2024
by Industry Intelligence Inc.
|
Biogen Inc. advocates for precision diagnostics, personalized medicine in healthcare; company emphasizes multidisciplinary approach for Spinal Muscular Atrophy care
Published:
September 17, 2024
by Industry Intelligence Inc.
|
Biogen launches Carisma-App for SMA patients, aiding in care management and research; company appoints Lloyd B. Minor and Sir Menelas Pangalos as new independent directors
Published:
September 13, 2024
by Industry Intelligence Inc.
|
US Patent Issued to Regeneron Pharmaceuticals on Sept. 10 for "Non-human animals models of retinoschisis" (New York Inventors)
Published:
September 11, 2024
by U.S. Fed News
|
Biogen advances SMA research, explores therapy potential; company partners with Bill Nye to raise ataxia awareness through National Ataxia Foundation collaboration
Published:
September 06, 2024
by Industry Intelligence Inc.
|
Ask us about our Government & Public Policy market view